Innate Pharma
Price & Volume
Stats
See more52W Range | $1.17-$2.71 |
Market Cap | $156.3M |
Shares Short | 126,864 |
Financials
See moreRevenue (12 Mos) | $9.8M |
Revenue Growth (YoY) | 16.5% |
Gross Profit (12 Mos) | -$30.1M |
Diluted EPS | -$0.59 |
News
See moreYahoo Finance • 9 days ago
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Yahoo Finance • last month
Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know
Yahoo Finance • 2 months ago
Innate Pharma Q2 Earnings Call Highlights
Yahoo Finance • 2 months ago
Innate Pharma gives H1 results
About
CEO | Mr. Jonathan E. Dickinson B.Sc., M.B.A. |
CFO | Mr. Frederic Lombard M.B.A. |
Address | 117, Avenue de Luminy, Marseille, France, 13009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 120 |